<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> result from an imbalance between vascular damage and regeneration </plain></SENT>
<SENT sid="1" pm="."><plain>Several circulating lineage-committed progenitor cells have been implicated, but no data are available on pericyte progenitor cells (PPCs) </plain></SENT>
<SENT sid="2" pm="."><plain>Based on the evidence that PPCs increase in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients after chemotherapy, we explored whether circulating PPC levels are affected by <z:chebi fb="105" ids="17234">glucose</z:chebi> control in type 2 diabetic patients, in relation to the presence of <z:hpo ids='HP_0011010'>chronic</z:hpo> complications </plain></SENT>
<SENT sid="3" pm="."><plain>We enumerated peripheral blood PPCs as Syto16+CD45-CD31-CD140b+ events by flow cytometry at baseline and after 3 and 6 months of <z:chebi fb="105" ids="17234">glucose</z:chebi> control by means of add-on basal insulin therapy on top of oral agents in 38 poorly controlled type 2 diabetic patients </plain></SENT>
<SENT sid="4" pm="."><plain>We found that, in patients with <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> (n = 23), the level of circulating PPCs increased about 2 fold after 3 months and then returned to baseline at 6 months </plain></SENT>
<SENT sid="5" pm="."><plain>In patients without <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> (control group, n = 15), PPCs remained fairly stable during the whole study period </plain></SENT>
<SENT sid="6" pm="."><plain>No relationship was found between change in PPCs and <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> (either peripheral, coronary, or cerebrovascular) </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that <z:chebi fb="105" ids="17234">glucose</z:chebi> control transiently mobilizes PPCs diabetic patients with <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Increase in PPCs may represent a vasoregenerative event or may be a consequence of ameliorated <z:chebi fb="105" ids="17234">glucose</z:chebi> control on microvascular lesions </plain></SENT>
</text></document>